SG11201605618WA - Selective nr2b antagonists - Google Patents
Selective nr2b antagonistsInfo
- Publication number
- SG11201605618WA SG11201605618WA SG11201605618WA SG11201605618WA SG11201605618WA SG 11201605618W A SG11201605618W A SG 11201605618WA SG 11201605618W A SG11201605618W A SG 11201605618WA SG 11201605618W A SG11201605618W A SG 11201605618WA SG 11201605618W A SG11201605618W A SG 11201605618WA
- Authority
- SG
- Singapore
- Prior art keywords
- nr2b antagonists
- selective nr2b
- selective
- antagonists
- nr2b
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461925363P | 2014-01-09 | 2014-01-09 | |
| PCT/US2015/010262 WO2015105772A1 (en) | 2014-01-09 | 2015-01-06 | Selective nr2b antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201605618WA true SG11201605618WA (en) | 2016-08-30 |
Family
ID=52463126
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201605618WA SG11201605618WA (en) | 2014-01-09 | 2015-01-06 | Selective nr2b antagonists |
Country Status (27)
| Country | Link |
|---|---|
| US (10) | US9221796B2 (en) |
| EP (1) | EP3092224B1 (en) |
| JP (1) | JP6543259B2 (en) |
| KR (1) | KR102311518B1 (en) |
| CN (1) | CN106061961B (en) |
| AR (1) | AR099071A1 (en) |
| AU (1) | AU2015205001A1 (en) |
| CA (1) | CA2936293A1 (en) |
| CL (1) | CL2016001763A1 (en) |
| DK (1) | DK3092224T3 (en) |
| EA (1) | EA201691413A1 (en) |
| ES (1) | ES2693250T3 (en) |
| HR (1) | HRP20181585T1 (en) |
| HU (1) | HUE041986T2 (en) |
| IL (1) | IL246599A0 (en) |
| LT (1) | LT3092224T (en) |
| MX (1) | MX2016008898A (en) |
| PE (1) | PE20160933A1 (en) |
| PL (1) | PL3092224T3 (en) |
| PT (1) | PT3092224T (en) |
| RS (1) | RS57830B1 (en) |
| SG (1) | SG11201605618WA (en) |
| SI (1) | SI3092224T1 (en) |
| TR (1) | TR201815579T4 (en) |
| TW (1) | TWI640515B (en) |
| UY (1) | UY35947A (en) |
| WO (1) | WO2015105772A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9221796B2 (en) * | 2014-01-09 | 2015-12-29 | Bristol-Myers Squibb Company | Selective NR2B antagonists |
| EP3362447B1 (en) * | 2015-10-14 | 2020-08-26 | Bristol-Myers Squibb Company | Selective nr2b antagonists |
| EA201890946A1 (en) | 2015-10-14 | 2018-09-28 | Бристол-Маерс Сквибб Компани | SELECTIVE ANTAGONISTS NR2B |
| CN108203404A (en) * | 2018-03-02 | 2018-06-26 | 上海博邦医药科技有限公司 | (R) synthetic method of -3- Phenylpiperidines or/and the chiral intermediate of (S) -3- Phenylpiperidines and Ni Lapani |
| US10781172B2 (en) | 2018-06-21 | 2020-09-22 | Northwestern University | Catalysts and methods for enantioselective conjugate additions of amines to unsaturated electrophiles |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2744448B1 (en) | 1996-02-02 | 1998-04-24 | Pf Medicament | NOVEL PIPERIDINES DERIVED FROM ARYL PIPERAZINE, AS WELL AS THEIR PREPARATION METHOD, PHARMACEUTICAL COMPOSITIONS AND THEIR USE AS MEDICAMENTS |
| WO2000063173A1 (en) | 1999-04-14 | 2000-10-26 | F. Hoffmann-La Roche Ag | Process for the preparation of substituted piperidines |
| US6476041B1 (en) | 1999-10-29 | 2002-11-05 | Merck & Co., Inc. | 1,4 substituted piperidinyl NMDA/NR2B antagonists |
| CZ20023479A3 (en) | 2000-04-26 | 2003-04-16 | Warner-Lambert Company | Cyclohexyl amine derivative, as a subtype of selective NMDA receptor antagonists |
| JPWO2003035641A1 (en) | 2001-10-22 | 2005-02-10 | 塩野義製薬株式会社 | New carbamoylpyrrolidone derivatives |
| DK1648882T3 (en) | 2003-06-04 | 2008-11-24 | Merck & Co Inc | 3-fluoro-piperidines as NMDA / NR2B antagonists |
| EP1673367A1 (en) | 2003-10-08 | 2006-06-28 | Pfizer, Inc. | Fused lactam compounds |
| JPWO2007099828A1 (en) | 2006-02-23 | 2009-07-16 | 塩野義製薬株式会社 | Nitrogen-containing heterocyclic derivatives substituted with cyclic groups |
| AU2008272964A1 (en) | 2007-06-29 | 2009-01-08 | Emory University | NMDA receptor antagonists for neuroprotection |
| US9221796B2 (en) * | 2014-01-09 | 2015-12-29 | Bristol-Myers Squibb Company | Selective NR2B antagonists |
-
2015
- 2015-01-05 US US14/589,205 patent/US9221796B2/en active Active
- 2015-01-06 CA CA2936293A patent/CA2936293A1/en not_active Abandoned
- 2015-01-06 MX MX2016008898A patent/MX2016008898A/en unknown
- 2015-01-06 WO PCT/US2015/010262 patent/WO2015105772A1/en active Application Filing
- 2015-01-06 ES ES15703328.3T patent/ES2693250T3/en active Active
- 2015-01-06 SI SI201530408T patent/SI3092224T1/en unknown
- 2015-01-06 EA EA201691413A patent/EA201691413A1/en unknown
- 2015-01-06 EP EP15703328.3A patent/EP3092224B1/en active Active
- 2015-01-06 JP JP2016545819A patent/JP6543259B2/en not_active Expired - Fee Related
- 2015-01-06 TR TR2018/15579T patent/TR201815579T4/en unknown
- 2015-01-06 PL PL15703328T patent/PL3092224T3/en unknown
- 2015-01-06 CN CN201580012735.9A patent/CN106061961B/en active Active
- 2015-01-06 SG SG11201605618WA patent/SG11201605618WA/en unknown
- 2015-01-06 PT PT15703328T patent/PT3092224T/en unknown
- 2015-01-06 DK DK15703328.3T patent/DK3092224T3/en active
- 2015-01-06 LT LTEP15703328.3T patent/LT3092224T/en unknown
- 2015-01-06 RS RS20181296A patent/RS57830B1/en unknown
- 2015-01-06 KR KR1020167021356A patent/KR102311518B1/en active IP Right Grant
- 2015-01-06 AU AU2015205001A patent/AU2015205001A1/en not_active Abandoned
- 2015-01-06 PE PE2016001107A patent/PE20160933A1/en not_active Application Discontinuation
- 2015-01-06 HU HUE15703328A patent/HUE041986T2/en unknown
- 2015-01-08 TW TW104100592A patent/TWI640515B/en not_active IP Right Cessation
- 2015-01-09 AR ARP150100065A patent/AR099071A1/en unknown
- 2015-01-09 UY UY0001035947A patent/UY35947A/en unknown
- 2015-10-13 US US14/882,041 patent/US20160081995A1/en not_active Abandoned
-
2016
- 2016-07-04 IL IL246599A patent/IL246599A0/en unknown
- 2016-07-08 CL CL2016001763A patent/CL2016001763A1/en unknown
-
2017
- 2017-05-25 US US15/604,904 patent/US20170258777A1/en not_active Abandoned
- 2017-09-15 US US15/706,172 patent/US20180000807A1/en not_active Abandoned
- 2017-12-19 US US15/846,672 patent/US20180110766A1/en not_active Abandoned
-
2018
- 2018-05-04 US US15/971,067 patent/US20180250283A1/en not_active Abandoned
- 2018-10-03 HR HRP20181585TT patent/HRP20181585T1/en unknown
- 2018-12-19 US US16/225,850 patent/US20190117638A1/en not_active Abandoned
-
2019
- 2019-06-27 US US16/454,831 patent/US20190314358A1/en not_active Abandoned
-
2020
- 2020-01-30 US US16/777,114 patent/US20200163949A1/en not_active Abandoned
- 2020-09-04 US US17/012,781 patent/US20210121453A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201411344D0 (en) | Cloning | |
| GB201412161D0 (en) | Structure | |
| GB2528078B (en) | Structure | |
| IL258611A (en) | Selective nr2b antagonists | |
| GB201412159D0 (en) | Morphable structure | |
| HRP20181585T1 (en) | Selective nr2b antagonists | |
| GB2522522B (en) | Structure | |
| DK3177838T3 (en) | Fluid-redirecting structure | |
| HRP20182016T1 (en) | Ethynyl derivatives | |
| GB201420865D0 (en) | Boring device | |
| GB201405651D0 (en) | Delivering an action | |
| PL3163300T3 (en) | Resistance structure | |
| PL2898913T3 (en) | Nozzle | |
| IL258603A (en) | Selective nr2b antagonists | |
| GB201419494D0 (en) | Variations | |
| GB2522039B (en) | I-beam | |
| TWM489693U (en) | Nozzle structure | |
| ZA201807767B (en) | Angiotensin-1-receptor antagonists | |
| PT3464324T (en) | Angiotensin-1-receptor antagonists | |
| GB201419398D0 (en) | Concept 82a | |
| GB201414186D0 (en) | Secure tip | |
| HU4455U (en) | Construction component set | |
| AU358011S (en) | Short stool | |
| GB201400123D0 (en) | Concept 82a |